Dr. Weinshenker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-2706Fax+1 434-243-5420
Summary
- Dr. Brian Weinshenker is a neurologist who practiced for 30 years at Mayo Clinic, Rochester MN and recently moved to the University of Virginia. He received his medical degree from University of Manitoba and has been in practice 42 years. He is experienced in general neurology, clinical research, spinal cord disorders, and neuroimmunology (multiple sclerosis).
Education & Training
- University of MinnesotaResidency, Neurology, 1982 - 1985
- University of ManitobaClass of 1978
Certifications & Licensure
- VA State Medical License 2022 - 2026
- MN State Medical License 1992 - 2022
- FL State Medical License 2017 - 2021
- American Board of Internal Medicine Internal Medicine
- Royal College of Physicians and Surgeons of CanadaPsychiatry and Neurology
Clinical Trials
- Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 7543 citationsDiagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaChris H. Polman, Stephen C. Reingold, Brenda Banwell, Michel Clanet, Jeffrey A. Cohen
Annals of Neurology. 2011-02-01 - 2768 citationsInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M. Wingerchuk, Brenda Banwell, Jeffrey Bennett, Philippe Cabre, William M. Carroll
Neurology. 2015-07-14 - 4190 citationsDiagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Brenda Banwell, Frederik Barkhof, William M. Carroll, Timothy Coetzee
The Lancet. Neurology. 2017-12-21
Journal Articles
- Diagnosis of Progressive Multiple Sclerosis from the Imaging PerspectiveBrian G Weinshenker, Brenda L Banwell, JAMA Neurology
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAmy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsAmy Kunchok, Allen J Aksamit, Sean J Pittock, Brian G Weinshenker, Andrew Mckeon, JAMA Neurology
- Join now to see all
Authored Content
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsMay 2020
Press Mentions
- CANbridge Forms Scientific Advisory Board to Guide Global Development of CAN106 in Complement-Mediated DiseasesJuly 6th, 2022
- Mayo Clinic Research in the News — 7/26/2021July 26th, 2021
- Suffering with Hiccups That Never Seem to Go AwayJuly 24th, 2021
- Join now to see all
Grant Support
- Interferon Gamma Polymorphisms And Gender Bias In MSNational Institute Of Neurological Disorders And Stroke2004
- Interferon Gamma Polymorphisms And Gender Bias In MSNational Institute Of Neurological Disorders And Stroke2002–2003
- Plasma Exchange In Severe Demyelinating DiseaseNational Institute Of Neurological Disorders And Stroke1995–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: